AORT (NYSE: AORT) insider sales listed; 14,911 shares vesting on 02/27/2026
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
The issuer filed a Form 144 related to the proposed sale of 14,911 common shares tied to restricted stock vesting dated 02/27/2026. The excerpt also lists recent sales by James Mackin: 30,921 shares on 12/02/2025 for $1,408,736.02, 30,921 shares on 12/03/2025 for $1,405,693.40, 20,962 shares on 02/23/2026 for $787,909.17, and 13,936 shares on 02/24/2026 for $497,416.25.
Positive
- None.
Negative
- None.
FAQ
What does AORT's Form 144 filing report?
The filing reports the proposed sale of 14,911 common shares arising from restricted stock vesting dated 02/27/2026. It lists the security type as common stock and identifies the broker as Fidelity Brokerage Services LLC on the NYSE.
What February 2026 transactions are shown in the AORT excerpt?
The excerpt shows a proposed sale of 14,911 shares from restricted stock vesting on 02/27/2026. It also records sales by James Mackin of 20,962 shares on 02/23/2026 and 13,936 shares on 02/24/2026 with stated proceeds.
Which broker and exchange are named in the AORT filing excerpt?
The excerpt names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker and lists the market as the NYSE. The listing appears alongside the described securities and sale dates.